Benign Migratory Glossitis and Hand–Foot Syndrome Co-occurrence in a Renal Cell Carcinoma Patient on Sorafenib

Benign Migratory Glossitis and Hand–Foot Syndrome Co-occurrence in a Renal Cell Carcinoma Patient on Sorafenib

Sorafenib, a multitargeted tyrosine kinase inhibitor, is used for advanced renal cell carcinoma but can cause various cutaneous side effects. We report the case of a 50-year-old male with metastatic renal cell carcinoma who developed both benign migratory glossitis (BMG) and hand–foot syndrome (HFS)...

Full description

Saved in:
Bibliographic Details
Main Authors: Ramamoorthy Logamoorthy, Ragul Raj Elango, Shruti Ganesh, Suganya Radhakrishnan, Kaliaperumal Karthikeyan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-04-01
Series:Clinical Dermatology Review
Subjects:
benign migratory glossitis
hand–foot syndrome
sorafenib
Online Access:https://journals.lww.com/10.4103/cdr.cdr_142_24
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journals.lww.com/10.4103/cdr.cdr_142_24

Similar Items